Intravenous ferric carboxymaltose for anaemia in pregnancy
Loading...
Date
2020-10
Journal Title
Journal ISSN
Volume Title
Publisher
Medip Academy
Abstract
Background: Anaemia in pregnancy is associated with unfavourable consequences both for the mother and the fetus and is a major cause of maternal and perinatal mortality and morbidity.Methods: The study was conducted over a period of one year in which 100 pregnant females who met the inclusion criteria were administered ferric carboxymaltose (FCM) preparation.Results: There was significant rise in mean haemoglobin and serum ferritin after transfusion of ferric maltose in the patients with very less adverse effects.Conclusions: FCM, because of its high efficacy and safety can revolutionize the management of iron deficiency anaemia (IDA) in pregnancy.
Description
Keywords
Iron deficiency anaemia, Ferric carboxymaltose, Haemoglobin
Citation
Gandotra Nikita, Zargar Shazia, Mahajan Neha. Intravenous ferric carboxymaltose for anaemia in pregnancy. International Journal of Research in Medical Sciences. 2020 Oct; 8(10): 3539-3542